Treatment

BI 3820768 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
This study tests a new medicine called BI 3820768 for advanced germ cell, endometrial, or ovarian cancers. It aims to find a safe dose and see if it shrinks tumours. This medicine helps your immune system fight cancer.
For: Advanced Relapsed or Refractory Germ Cell Tumours · Advanced Relapsed or Refractory Endometrial Cancer · Advanced Relapsed or Refractory Ovarian Cancer
United States · Belgium · France